Prognosis prediction of stage II colon cancer by gene expression profiling by Capella, MG, Van Laar, R, Moreno, A, Marijnen, C, Van Velthuysen, L, Morreau, H, Westerga, J, Mager, R, Kerr, D, Tollenaar, R, Van't Veer, L

An information-theoretic analysis of genetics, gender and age in cancer patients. by Atwal, G, Rabadán, R, Lozano, G, Strong, L, Ruijs, M, Schmidt, M, van't Veer, L, Nevanlinna, H, Tommiska, J, Aittomäki, K, Bougeard, G, Frebourg, T, Levine, A, Bond, G

Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. by Salazar, R, Roepman, P, Capella, G, Moreno, V, Simon, I, Dreezen, C, Lopez-Doriga, A, Santos, C, Marijnen, C, Westerga, J, Bruin, S, Kerr, D, Kuppen, P, van de Velde, C, Morreau, H, Van Velthuysen, L, Glas, A, Van't Veer, L, Tollenaar, R

Fine-scale mapping of the FGFR2 breast cancer risk locus: Putative functional variants differentially bind FOXA1 and E2F1 by Meyer, K, O'Reilly, M, Michailidou, K, Carlebur, S, Edwards, S, Edwards, S, French, J, French, J, Prathalingham, R, Dennis, J, Bolla, M, Wang, Q, De Santiago, I, Hopper, J, Tsimiklis, H, Apicella, C, Southey, M, Schmidt, M, Broeks, A, Van 't Veer, L, Hogervorst, F, Muir, K, Muir, K, Lophatananon, A, Stewart-Brown, S

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. by Meyer, K, O'Reilly, M, Michailidou, K, Carlebur, S, Edwards, S, French, J, Prathalingham, R, Dennis, J, Bolla, M, Wang, Q, de Santiago, I, Hopper, J, Tsimiklis, H, Apicella, C, Southey, M, Schmidt, M, Broeks, A, Van 't Veer, L, Hogervorst, F, Muir, K, Lophatananon, A, Stewart-Brown, S, Siriwanarangsan, P, Fasching, P, Lux, M

Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. by Stevens, K, Garcia-Closas, M, Fredericksen, Z, Kosel, M, Pankratz, V, Hopper, J, Dite, G, Apicella, C, Southey, M, Schmidt, M, Broeks, A, Van 't Veer, L, Tollenaar, R, Fasching, P, Beckmann, M, Hein, A, Ekici, AB, Johnson, N, Peto, J, dos Santos Silva, I, Gibson, L, Sawyer, E, Tomlinson, I, Kerin, M, Chanock, S

Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. by Figueroa, J, Garcia-Closas, M, Humphreys, M, Platte, R, Hopper, J, Southey, M, Apicella, C, Hammet, F, Schmidt, M, Broeks, A, Tollenaar, R, Van't Veer, L, Fasching, P, Beckmann, M, Ekici, AB, Strick, R, Peto, J, dos Santos Silva, I, Fletcher, O, Johnson, N, Sawyer, E, Tomlinson, I, Kerin, M, Burwinkel, B, Marme, F

Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. by Lin, W, Camp, N, Ghoussaini, M, Beesley, J, Michailidou, K, Hopper, J, Apicella, C, Southey, M, Stone, J, Schmidt, M, Broeks, A, Van't Veer, L, Th Rutgers, E, Muir, K, Lophatananon, A, Stewart-Brown, S, Siriwanarangsan, P, Fasching, P, Haeberle, L, Ekici, AB, Beckmann, M, Peto, J, Dos-Santos-Silva, I, Fletcher, O, Johnson, N

Somatic mutations reveal asymmetric cellular dynamics in the early human embryo by Ju, Y, Martincorena, I, Gerstung, M, Petljak, M, Alexandrov, L, Rahbari, R, Wedge, D, Davies, H, Ramakrishna, M, Fullam, A, Martin, S, Alder, C, Patel, N, Gamble, S, O'Meara, S, Giri, D, Sauer, T, Pinder, S, Purdie, C, Borg, Å, Stunnenberg, H, van de Vijver, M, Tan, B, Caldas, C, Tutt, A, Ueno, N, van 't Veer, L, Martens, J, Sotiriou, C, Knappskog, S, Span, P, Lakhani, S, Eyfjörd, J, Børresen-Dale, A, Richardson, A, Thompson, A, Viari, A, Hurles, M, Nik-Zainal, S, Campbell, P, Stratton, M